chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: FLU4
Symptoms: Extra dose administered, No adverse event
Clinical narrative: patient that had received two Fluzone Quad vaccinations during this flu season. The first one was administered on 10/2/2020 and the second one on 01/17/2021/no AE; Initial information received on 08-Jan-2021 regarding an unsolicited valid non-serious case received from an other health professional.  This case involved a 57 year old female patient who received 0.5 ml of two INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (lot number: UJ506AB and expiry date: 30-Jun-2021) via unknown route in right deltoid for prophylactic vaccination during this flu season. The first one was administered on 02-Oct-2020 and the second one on 07- Jan-2021 (Extra dose administered).  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.  It was an actual medication error case due to extra dose administered (latency 3 months 5 days post the first dose).   At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 0.58
Sex: M
Vaccine: DTAPIPV, DTAPIPVHIB
Symptoms: Wrong product administered
Clinical narrative: an infant was administered Quadracel instead of Pentacel with no AE; Initial information regarding this unsolicited valid non-serious case from the via Global Medical Information (GMI) (Reference number- 00418272) was received from nurse and transmitted to Sanofi on 08-Jan-2021.  This case involved a 7 months old male patient who received a 0.5 ml dose of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] instead of DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] (lot: C5755AB, expiration date: 10-Jul-2022), an infant was administered Quadracel instead of Pentacel (Wrong vaccine administered). The dose was given in the right thigh via intramuscular route.  The patient's medical history, medical treatments, vaccinations and family history were not provided.  Concomitant medication included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVENAR 13) for Immunisation; ROTAVIRUS VACCINE (ROTAVIRUS VACCINE) for Immunisation; and INFLUENZA VACCINE (INFLUENZA VACCINE).  It was a potential medication error due to wrong vaccine administered (Wrong product administered).  At the time of reporting, the vaccine was administered.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 65.0
Sex: F
Vaccine: FLU4, FLU4
Symptoms: Extra dose administered
Clinical narrative: inadvertently administered Fluzone Quadrivalent instead of Prevnar with no AE; inadvertently administered Fluzone Quadrivalent High-Dose vaccine and Fluzone Quadrivalent instead on same day with no AE; Initial information regarding this unsolicited valid non-serious case was received from Pharmacist via The Agency (Reference number- 00422121) and transmitted to Sanofi on 08-Jan-2021.  This case involves a 65 years old female patient who received a dose of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (prefilled syringe, lot UJ565AB, expiration date 30-Jun-2021) via intramuscular route in the left deltoid and then inadvertently received a 0.5ml dose of INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (prefilled syringe, lot UJ442AA, expiration 30 June 2021) via intramuscular route in the right deltoid both for prophylactic vaccination (extra dose administered) instead of PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) [PREVENAR] on 08-Jan-2021 (wrong product administered).  The patient's medical history, medical treatments, vaccinations and family history were not provided. Patient received no other concomitant vaccines.   It was a actual medication error due to wrong vaccine administered and extra dose administered (latency-same day).   At the time of reporting, no adverse event was reported.  The reporter stated that she grabbed the Fluzone Quadrivalent prefilled syringe box instead of the Prevnar box because the boxes for the two vaccines look very similar. Prevnar was not administered. Repoert stated that doctor information not available since the vaccines were administered at a retail pharmacy. The reporter had been trying to reach the patient, but not spoken to the patient since the error.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: IPV
Symptoms: No adverse event, Product storage error
Clinical narrative: Ipol that was not suitable for use due to being involved in the temperature excursion with no AE; Initial information regarding this unsolicited valid non-serious case from the via Global Medical Information (GMI) (Reference number- 00422264) was received from Other Healthcare Professional on 08-Jan-2021.  This case involved seven patients (unknown demographic) who received dose of IPV (VERO) [IPOL] (lot number and expiration date not reported), that was not suitable for use due to being involved in the temperature excursion (product storage error). [caller did not have patient information or had the vaccine information]  The patient's medical history, medical treatments, vaccinations, concomitant medications and family history were not provided.  It was a case of actual medication error due to incorrect product storage error.  It was reported, nurse advised punctured IPOL was given to patients after temperature excursion in which they had gone out of range wanted to know if they should re-vaccinate those patients.  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  There will be no information available on batch number for this case.
Sex: U
Vaccine: MNQ
Symptoms: Extra dose administered
Clinical narrative: patient inadvertently received 2 doses of Menacta 1 year apart from 2 different providers with no AE; Initial information was received on 14-Jan-2021 regarding an unsolicited non-valid non-serious case from a physician.  This case involves a 13 years old patient who inadvertently received 2 doses of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] 1 year apart on unknown dates from 2 different providers (extra dose administered) (lot number: unknown and expiry date: unknown] via an unknown route at an unknown administration site for prophylactic vaccination.  Medical history, past medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications were not reported.  It was an actual medication error due to extra dose administered (latency: unknown). Reporter wanted to know if there were any concerns after this error.  At the time of report, no adverse event was reported.  Disclaimer: This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  There will be no information available regarding batch number in this case.
Sex: U
Vaccine: DTAPIPVHIB
Symptoms: No adverse event, Product preparation issue
Clinical narrative: A patient received a partial dose of PENTACEL, whereby DTaP and IPV were administered, but the HIB was not, no AE; Initial information was received on 14-Jan-2021 regarding an unsolicited valid non-serious case from a consumer/non-health care professional.  This case involves a patient (demographics unknown) who received a partial dose of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] whereby DTAP and IPV were administered, but the HIB was not, (batch number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination on an unknown date (Product preparation issue). Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   It was a case of an actual medication error due to Inappropriate reconstitution technique (latency same day).  The reporter asked if the HIB could be given separately  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  There will be no information available on the batch number for this case.
Age: 80.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Illness, Inappropriate schedule of product administration, Social problem
Clinical narrative: Become ill; 1st dose of Shingrix on August 2018 and has not completed the schedule/because of the pandemic, the patient did not receive the 2nd dose; This case was reported by a pharmacist and described the occurrence of illness in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In August 2018, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced illness and social problem. On an unknown date, the outcome of the illness and social problem were unknown.   The reporter considered the illness to be unrelated to Shingrix.  Additional information was provided as follows: The age at vaccination was not applicable for 2nd dose. The patient did not complete the schedule.  The patient become ill a time later after receiving the 1st dose (he said it was not related to the vaccine, did not specify which illness) and then because of the pandemic, the patient did not receive the 2nd dose. The reporter did not have vaccination details but agreed to follow up.
Age: 4.0
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: no adverse event; temperature excursion; This spontaneous report was received from a registered nurse referring to a 4 years old patient of unknown gender. The patient's concomitant medication, pertinent medical history and drug allergies or reactions were not reported.   On 07-DEC-2020, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strength and route of administration were not reported, lot # T021638, expiration date was 21-DEC-2021) 0.5 ml for prophylaxis.         It was reported that the suspect vaccine was exposed to a temperature of minus 13.3 degree Celsius for a time frame of 4 hours and 15 minutes, as recorded by the digital data logger (product storage error). There were no previous temperature excursions. No further adverse event (AE) information was provided.  This is one of the several reports reported by the same reporter.; Sender's Comments:  US-009507513-2012USA013093: US-009507513-2012USA013095: US-009507513-2012USA013501: US-009507513-2012USA013524: US-009507513-2012USA013539: US-009507513-2012USA013585: US-009507513-2012USA013592: US-009507513-2012USA013594: US-009507513-2012USA013598: US-009507513-2012USA013601: US-009507513-2101USA000121: US-009507513-2101USA000122: US-009507513-2101USA000144: US-009507513-2101USA000266: US-009507513-2101USA000151:
Age: 83.0
Sex: U
Vaccine: PPV
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE/PQC reported; Caller is HBP reporting an improperly stored, administered PNUEMOVAX 23 VIAL; This spontaneous report was received from a hospital-based physician (HBP) and refers to a 83-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.      On 05-JAN-2021, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot # T021329, expiration date 03-OCT-2021, 0.5 milliliter for prophylaxis (anatomical location and route of administration were not reported).     Digital Data logger was involved. The vaccine was stored at the temperature that was reported as 8.9 degrees of Celsius for 72 hours. There was no previous temperature excursion reported.  No additional adverse event or product quality complaint was reported
Sex: U
Vaccine: MMRV
Symptoms: Product preparation issue
Clinical narrative: no additional AE; expired dose administered; This spontaneous report was received from a other health professional and refers to a 4 years-old patient. The patient's concurrent conditions, medical history, concomitant medications, drugs reactions or allergies were not provided  On 05-JAN-2020, the patient was vaccinated with expired measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (lot # S017250, expiration date 01-DEC-2020) 0.5 ml, once (route of administration was not provided) for prophylaxis. The vaccine was reconstituted with a sterile diluent . No adverse event occurred. The outcome of adverse events was not provided.
Sex: M
Vaccine: MEN
Symptoms: Nasopharyngitis, Pyrexia
Clinical narrative: Fever; Cold symptoms; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a male patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   On an unknown date, the patient received Meningococcal B vaccine. On an unknown date, 1 day after receiving Meningococcal B vaccine, the patient experienced fever and cold symptoms. On an unknown date, the outcome of the fever and cold symptoms were unknown.   It was unknown if the reporter considered the fever and cold symptoms to be related to Meningococcal B vaccine.  Additional information was provided as follows: The case was reported by the parent who reported for son. The age at vaccination was not reported. The patient received Meningococcal B vaccine and experienced terrible fever and cold symptoms the very next day.
Age: 57.0
Sex: M
Vaccine: VARZOS
Symptoms: Arthralgia, Asthenia, Chills, Hyperhidrosis, Muscle tightness
Clinical narrative: Neck pain and tightness; Shoulder pain; Bicep pain; Neck tightness; Chills; Fever; Aches; Sweats; Headache; Lack of energy; This case was reported by a consumer and described the occurrence of chills in a 57-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles.   On 20th November 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 20th November 2020, less than a day after receiving Shingrix, the patient experienced chills, fever, pain, sweating, headache and loss of energy. On 21st November 2020, the patient experienced neck pain, shoulder pain, muscle pain and neck tightness. On 22nd November 2020, the outcome of the chills, fever, pain, sweating, headache and loss of energy were recovered/resolved. On an unknown date, the outcome of the neck pain, shoulder pain, muscle pain and neck tightness were not recovered/not resolved.   It was unknown if the reporter considered the chills, fever, pain, sweating, headache, loss of energy, neck pain, shoulder pain, muscle pain and neck tightness to be related to Shingrix.  Additional details were provided as follows: The patinet received 2nd dose of Shingrix in left arm.  After receiving 2nd dose of Shingrix, the patient experienced chills, fever, aches, sweats, headache, lack of energy, neck pain and tightness, and shoulder and bicep pain. The patient states he sought medical treatment for the neck, shoulder and bicep pain, was prescribed medication, and that it has not helped. The patient states that neck pain and tightness, and shoulder and bicep pain symptoms have grown more painful over time and are still on going. The customer does not have vaccine information for this adverse event. The reporter consent to follow up.
Age: 57.0
Sex: M
Vaccine: VARZOS
Symptoms: Myalgia, Neck pain, Pain, Pyrexia
Clinical narrative: Neck pain and tightness; Shoulder pain; Bicep pain; Neck tightness; Chills; Fever; Aches; Sweats; Headache; Lack of energy; This case was reported by a consumer and described the occurrence of chills in a 57-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles.   On 20th November 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 20th November 2020, less than a day after receiving Shingrix, the patient experienced chills, fever, pain, sweating, headache and loss of energy. On 21st November 2020, the patient experienced neck pain, shoulder pain, muscle pain and neck tightness. On 22nd November 2020, the outcome of the chills, fever, pain, sweating, headache and loss of energy were recovered/resolved. On an unknown date, the outcome of the neck pain, shoulder pain, muscle pain and neck tightness were not recovered/not resolved.   It was unknown if the reporter considered the chills, fever, pain, sweating, headache, loss of energy, neck pain, shoulder pain, muscle pain and neck tightness to be related to Shingrix.  Additional details were provided as follows: The patinet received 2nd dose of Shingrix in left arm.  After receiving 2nd dose of Shingrix, the patient experienced chills, fever, aches, sweats, headache, lack of energy, neck pain and tightness, and shoulder and bicep pain. The patient states he sought medical treatment for the neck, shoulder and bicep pain, was prescribed medication, and that it has not helped. The patient states that neck pain and tightness, and shoulder and bicep pain symptoms have grown more painful over time and are still on going. The customer does not have vaccine information for this adverse event. The reporter consent to follow up.
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: Pain in her injected arm/pain at site of injection; This case was reported by a consumer and described the occurrence of pain in arm in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included diabetes. Concomitant products included metformin hydrochloride (Glucophage) and glimepiride.   In September 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 4 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient had reported the case for herself. The age at vaccination was not reported. The patient received vaccine in an unknown arm. The patient had pain in her injected arm but it went away. The reporter did not consent to follow-up.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Major depression, Myalgia, Pyrexia
Clinical narrative: Low-grade fever, muscle and joint pain, major depressive episode
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: When I got out of bed Saturday morning, Jan. 16, 2021, or Sunday, Jan. 17, both of my hips were extremely painful. I had never felt pain in my hips and was alarmed by it. I didn't associate the pain with the COVID-19 vaccination until Jan. 22, when I heard a doctor in a video from the Health Department talking about the vaccinations. The city communication system had sent the link to me, unrequested, in an email. The doctor listed possible side effects, including hip pain. I searched the internet for lists of side effects, although I had read them in newspaper reports and had heard them in coverage of the pandemic and vaccines. I was unaware of hip pain specifically or joint pain being on the list.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site rash, Injection site swelling
Clinical narrative: Red raised rash with swelling on arm at injection site that lasted for 5 days
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling
Clinical narrative: I now have a red and itchy rash with a lump by the injection site it?s  8 days since I received the first shot of the moderna vaccine
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Syncope
Clinical narrative: vasovagal response shortly after sitting down in observation area.  pt was placed safely on floor, feet raised and regained alertness. 911 was called, vitals including Blood pressure, heart rate and alertness and orientation were monitored every 2 mins.  pt was improved shortly after feet raised. the patient later returned to the pharmacy ( 2 hours later) saying he is fine, and was told his anxiety caused the event.   pt did not go to the hospital.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Chest pain, Electrocardiogram, Electrocardiogram ambulatory, Haematology test
Clinical narrative: Per the ED Physician documentation and report from family, patient had been experiencing some chest pain for the last week to week and a half  with SVT before presenting to the emergency department. patient had a holter monitor study earlier in the week that results were pending.  1/23/21- patient arrives to the ED via ambulance with complaints of sharp chest pain, palpitations and heart rate in 150's. Patients troponin level then elevated and it was determined patient was having a NSTEMI.  1/24/21- patient had recurrent episodes of SVT and family decided patient would benefit from further cardiac workup so she was transferred to a higher level of care. Unknown if patient has discharge from the facility we transferred her to.  This patient is felt to be of significance since she is 1/3 patients currently in our facility who developed cardiac/blood issues post vaccination from the same pharmacy with the same lot number vaccine. VAERS reports were put in for all three to determine if further investigation is needed.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Palpitations, Supraventricular tachycardia, Troponin increased
Clinical narrative: Per the ED Physician documentation and report from family, patient had been experiencing some chest pain for the last week to week and a half  with SVT before presenting to the emergency department. patient had a holter monitor study earlier in the week that results were pending.  1/23/21- patient arrives to the ED via ambulance with complaints of sharp chest pain, palpitations and heart rate in 150's. Patients troponin level then elevated and it was determined patient was having a NSTEMI.  1/24/21- patient had recurrent episodes of SVT and family decided patient would benefit from further cardiac workup so she was transferred to a higher level of care. Unknown if patient has discharge from the facility we transferred her to.  This patient is felt to be of significance since she is 1/3 patients currently in our facility who developed cardiac/blood issues post vaccination from the same pharmacy with the same lot number vaccine. VAERS reports were put in for all three to determine if further investigation is needed.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute left ventricular failure, Acute respiratory failure, Anaemia, COVID-19
Clinical narrative: Pt admitted 22 Jan 21 with (HFpEF) heart failure with preserved ejection fraction; AKI (acute kidney injury); Acute kidney injury superimposed on chronic kidney disease; Acute on chronic diastolic congestive heart failure; Acute on chronic heart failure with preserved ejection fraction; Acute respiratory failure with hypoxia; Anemia due to stage 3 chronic kidney disease, unspecified whether stage 3a or 3b CKD; Anemia, unspecified type; COVID-19; Chest pain; Chronic pain syndrome; Gastroesophageal reflux disease without esophagitis; History of COVID-19; Hypertension, essential; Hypertensive heart and kidney disease with HF and with CKD stage II; Hypoxia; Peripheral vascular disease due to secondary diabetes mellitus; Prostate cancer; Shortness of breath; Type 2 diabetes mellitus with stage 3 chronic kidney disease, with long-term current use of insulin, unspecified whether stage 3a or 3b CKD as of today still hospitalized
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure, Cardiac failure acute, Cardiac failure congestive, Chest pain, Chronic kidney disease
Clinical narrative: Pt admitted 22 Jan 21 with (HFpEF) heart failure with preserved ejection fraction; AKI (acute kidney injury); Acute kidney injury superimposed on chronic kidney disease; Acute on chronic diastolic congestive heart failure; Acute on chronic heart failure with preserved ejection fraction; Acute respiratory failure with hypoxia; Anemia due to stage 3 chronic kidney disease, unspecified whether stage 3a or 3b CKD; Anemia, unspecified type; COVID-19; Chest pain; Chronic pain syndrome; Gastroesophageal reflux disease without esophagitis; History of COVID-19; Hypertension, essential; Hypertensive heart and kidney disease with HF and with CKD stage II; Hypoxia; Peripheral vascular disease due to secondary diabetes mellitus; Prostate cancer; Shortness of breath; Type 2 diabetes mellitus with stage 3 chronic kidney disease, with long-term current use of insulin, unspecified whether stage 3a or 3b CKD as of today still hospitalized
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Gastrooesophageal reflux disease, Hypoxia, Pain
Clinical narrative: Pt admitted 22 Jan 21 with (HFpEF) heart failure with preserved ejection fraction; AKI (acute kidney injury); Acute kidney injury superimposed on chronic kidney disease; Acute on chronic diastolic congestive heart failure; Acute on chronic heart failure with preserved ejection fraction; Acute respiratory failure with hypoxia; Anemia due to stage 3 chronic kidney disease, unspecified whether stage 3a or 3b CKD; Anemia, unspecified type; COVID-19; Chest pain; Chronic pain syndrome; Gastroesophageal reflux disease without esophagitis; History of COVID-19; Hypertension, essential; Hypertensive heart and kidney disease with HF and with CKD stage II; Hypoxia; Peripheral vascular disease due to secondary diabetes mellitus; Prostate cancer; Shortness of breath; Type 2 diabetes mellitus with stage 3 chronic kidney disease, with long-term current use of insulin, unspecified whether stage 3a or 3b CKD as of today still hospitalized
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hyperhidrosis, Pain in extremity
Clinical narrative: 10 hours post vaccine - chills, fatigue, headache, sweats. Arm a bit sore but not as bad as dose 1.  sx subsided within 36 hrs
Age: 57.0
Sex: F
Vaccine: UNK
Symptoms: Blood creatine increased, Blood pressure increased, Blood urea increased, Confusional state, Dizziness
Clinical narrative: Confusion, dizzy, vomiting, sky high blood pressure 230/125, elevated BUN and Creatine, had EKG and IVs
Age: 57.0
Sex: F
Vaccine: UNK
Symptoms: Electrocardiogram, Vomiting
Clinical narrative: Confusion, dizzy, vomiting, sky high blood pressure 230/125, elevated BUN and Creatine, had EKG and IVs
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site oedema, Myalgia, Pruritus
Clinical narrative: I started experiencing muscle pain again and pruritus in my vaccinated arm (left) and an area of epidermis (approximately 4"x6") around the vaccination site is also showing moderate erythema and slight edema on 1/20/21 (12 days after dose 1). I staring applying 1% hydrocortisone cream on the affected area and taking Benadryl 25mg tablets. The pruiritus started to lessen however the erythema and edema did not decrease so I contacted my primary care provider. She referred me to an allergist who I saw via telehealth on 1/25/21. By that time the pruiritus, erythema, and edema was almost gone however I did show her a picture when the reaction was at its most severe state. As of today, it is still present but continues to resolve. My allergist discussed the reported incidence of this reaction, informed me that it did not contraindicate me from receiving the 2nd dose, and that this reaction may or may not occur again.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cardiac failure acute, Cardiac failure congestive, Chest pain, Coronary artery disease
Clinical narrative: Pt. admitted to the hospital on 22 Jan 21 with Acute on chronic combined systolic and diastolic congestive heart failure; CHF (congestive heart failure); Chest pain, unspecified type; Coronary artery disease involving native coronary artery of native heart without angina pectoris; Debility; Ischemic cardiomyopathy; Shortness of breath; Systolic and diastolic CHF, acute on chronic Still admitted as of today
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Ischaemic cardiomyopathy, Left ventricular failure
Clinical narrative: Pt. admitted to the hospital on 22 Jan 21 with Acute on chronic combined systolic and diastolic congestive heart failure; CHF (congestive heart failure); Chest pain, unspecified type; Coronary artery disease involving native coronary artery of native heart without angina pectoris; Debility; Ischemic cardiomyopathy; Shortness of breath; Systolic and diastolic CHF, acute on chronic Still admitted as of today
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: I had a prolonged nosebleed. i could not get it to stop for 20 minutes, i held my nose, took a shower. I have not had a nose bleed in years. I was so strange. Even when i was younger it would typically stop after 1-2 minutes. but this was just a prolonged bleed. I was concerned that my platelets were low and making an appointment to get them checked. As i read information about ITP but i wanted to insert this as a possible vaccine VAERS in case others experiences a similar manifestation after the vaccine
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Sensitive skin
Clinical narrative: 3 inches below the injection site an area of about the size of 2x4" was raised (swollen), red, warm to touch, and sensitive to touch.  Patient  did not put anything on it or took anything for it.   Reported to pharmacist on 1/22/2021, came in on 1/25/2021 and it was no longer swollen or red.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Injection site swelling, Lip swelling, Nausea, Pharyngeal swelling
Clinical narrative: Whole body itching Nausea Slight swelling of airway and lower lip Feeling of anxiety Above symptoms started w/I 20 min of injection, still itchy and taking Benadryl at 2300 Swelling at site of injection about the size of a small orange
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Whole body itching Nausea Slight swelling of airway and lower lip Feeling of anxiety Above symptoms started w/I 20 min of injection, still itchy and taking Benadryl at 2300 Swelling at site of injection about the size of a small orange
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Bilateral forearm bumps/rash
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: Awoke the morning after receiving the 2nd dose of the Pfizer COVID vaccine with low-grade fever, slight headache which worsened throughout the day, chills, and body aches.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Fatigue, Feeling abnormal, Headache, Injection site pain
Clinical narrative: Headache, Muscle aches, a "buzzy" feeling in the body, GI upset, brain fog, exhaustion upon arising and in the evenings. Soreness at injection site lasted 2 days, the other symptoms lasted four full days.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Headache, Muscle aches, a "buzzy" feeling in the body, GI upset, brain fog, exhaustion upon arising and in the evenings. Soreness at injection site lasted 2 days, the other symptoms lasted four full days.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal distension, Abdominal pain, Abdominal pain upper, Asthenia, Benign prostatic hyperplasia
Clinical narrative: Pt. admitted to hospital on 23 Jan 21 with  Abdominal distention; Abdominal pain; Benign prostatic hyperplasia without lower urinary tract symptoms; Bilateral lower extremity edema; Chest pain; Essential hypertension; Generalized abdominal pain; Lower extremity edema; Mesenteric mass; Pain of upper abdomen; Shortness of breath; Weakness Discharged 25 Jan 21
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Essential hypertension, Mesenteric neoplasm, Oedema peripheral
Clinical narrative: Pt. admitted to hospital on 23 Jan 21 with  Abdominal distention; Abdominal pain; Benign prostatic hyperplasia without lower urinary tract symptoms; Bilateral lower extremity edema; Chest pain; Essential hypertension; Generalized abdominal pain; Lower extremity edema; Mesenteric mass; Pain of upper abdomen; Shortness of breath; Weakness Discharged 25 Jan 21
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Facial paralysis, Injection site pain, Musculoskeletal stiffness, Pain
Clinical narrative: 1/18/2021- injection right arm  1/19/2021- mild pain at injection sight. Body aches. 1/20/2021- mild pain and muscle stiffness at injection sight. Chills and body aches.  1/21/2021woke up with itching on left side of face a scalp. 1/22/2021 itching subsided 1/23/2021- left side face drooping started.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: 1/18/2021- injection right arm  1/19/2021- mild pain at injection sight. Body aches. 1/20/2021- mild pain and muscle stiffness at injection sight. Chills and body aches.  1/21/2021woke up with itching on left side of face a scalp. 1/22/2021 itching subsided 1/23/2021- left side face drooping started.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Mental status changes
Clinical narrative: Pt. admitted on 23 jan 21 with AMS, Chest pain; Shortness of breath.  He was discharged on 21 Jan 21
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site pain, Pain in extremity, Peripheral swelling, Pruritus
Clinical narrative: Exactly one week after receiving the shot, I woke up to arm pain, a very swollen arm, (like a large lump), itching and redness. It was a delayed reaction. One day later, the swelling went down but the redness spread. Five days after my symptoms appeared, I am doing much better but my arm is still a little itchy. I am reporting it per my doctor?s advice because it was strange and how it was a week delayed. I did have injection site pain the day following but no swelling or redness like what happened a week later. Is it safe for me to get the second shot?
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Facial pain, Facial paresis, Hypoaesthesia
Clinical narrative: I had sudden onset moderate left facial pain then mild weakness and numbness on the left side of my face. It?s slightly better now but has not resolved. It started about 3 hours after my vaccine. No other symptoms.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Injection site erythema, Injection site swelling, Movement disorder, Pain
Clinical narrative: Moderately severe pain which made basic movements difficult and woke me up frequently throughout the night beginning evening of vaccination on 1/14/2021 and steadily worsening through the next day and night. Large oblong welt about 2 inches across at injection site. Symptoms started within a few hours of getting the injection and became steadily very significant by the next day. It took about 7 days to recover from the most significant symptoms and was still recovering from mild bruise and occasional itching but no redness. Today (1/26/2021) my arm started itching again, and I see that I have a large flat circular (about 2 inches across) red spot right where I had the welt a week ago.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Sleep disorder
Clinical narrative: Moderately severe pain which made basic movements difficult and woke me up frequently throughout the night beginning evening of vaccination on 1/14/2021 and steadily worsening through the next day and night. Large oblong welt about 2 inches across at injection site. Symptoms started within a few hours of getting the injection and became steadily very significant by the next day. It took about 7 days to recover from the most significant symptoms and was still recovering from mild bruise and occasional itching but no redness. Today (1/26/2021) my arm started itching again, and I see that I have a large flat circular (about 2 inches across) red spot right where I had the welt a week ago.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site extravasation
Clinical narrative: Patient received first dose of the Pfizer COVID vaccination series.  After administration by nurse, there was concern that the injection site was away from the deltoid muscle and that a portion of the injection leaked out of the body and was present on the skin surface.  Concern for incomplete administration of the first dose of the Pfizer COVID vaccination series.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein increased, Chest X-ray normal, Chills, Computerised tomogram thorax, Full blood count
Clinical narrative: Moderna COVID-19 Vaccine. Headache and nausea onset 12 hours after vaccine was given. Chills/body aches and fever were present 18 hours after injection. Fever remained between 101.2 and 102.4, with a spike of 103.4 on 1/14/2021. Headache and nausea lasted approximately 24 hours, while fever and chills/body aches lasted for 5 days after vaccine was administered. An Emergency Room visit to Hospital was made on 1/15/2021 into 1/16/2021 for these symptoms since they had lasted over 48 hours. Negative on all tests, with elevated inflammation levels. X-ray and CT scan of chest revealed no pneumonia or blood clots.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain, Pyrexia
Clinical narrative: Moderna COVID-19 Vaccine. Headache and nausea onset 12 hours after vaccine was given. Chills/body aches and fever were present 18 hours after injection. Fever remained between 101.2 and 102.4, with a spike of 103.4 on 1/14/2021. Headache and nausea lasted approximately 24 hours, while fever and chills/body aches lasted for 5 days after vaccine was administered. An Emergency Room visit to Hospital was made on 1/15/2021 into 1/16/2021 for these symptoms since they had lasted over 48 hours. Negative on all tests, with elevated inflammation levels. X-ray and CT scan of chest revealed no pneumonia or blood clots.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling, Injection site warmth
Clinical narrative: Exactly a week after the vaccine I have a red, itchy, hot to touch rash, right over the injection site. Raised bumps.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Electrocardiogram, Headache, Hypertension
Clinical narrative: high heart rate of 130s, headache, extreme weakness, high blood pressure,  nausea and vomiting, fever and headache, chills, pain all over
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Vomiting
Clinical narrative: high heart rate of 130s, headache, extreme weakness, high blood pressure,  nausea and vomiting, fever and headache, chills, pain all over
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Myalgia, Pyrexia
Clinical narrative: Expected side effects were noticed roughly 15hrs after vaccine was received. At approximately 18hrs post vaccination elevated temperature was documented. My temperature continued to increase throughout the day. By 10pm on January 11th all symptoms experienced post vaccine had resolved.  Below is a timeline of events as well as measures taken during recovery phase.  - Severe chills associated with elevated temperature. Highest documented temperature  was 102.1 roughly 24hrs post vaccination. Severe muscle aches in bilateral lower extremities (during elevated temp only). Moderate bilateral hip pain (during elevated temp as well).  No were antipyretics taken during this event.  Oral water intake increased during these hours.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: swelling, redness, and itching at injection site, along with a slight headache.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Constipation, Headache, Joint swelling, Peripheral swelling
Clinical narrative: 29 y/o F otherwise well noting no symptoms the morning of recieving her 1st dose Moderna COVID19 vaccination. 8 hours following the vaccination and exercising from the gym, patient noted headache, chills, a fever of 101.2F, and constipation. Patient did report mild improvement of symptoms after taking motrin and tylenol with slow improvement of symptoms though complaints 5 days later for increased swelling of ankles/feet/wrists/ankles bilaterally of unknown cause. No new dietary changes, foods consumed, medications, or history of similar issues in the past.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: 29 y/o F otherwise well noting no symptoms the morning of recieving her 1st dose Moderna COVID19 vaccination. 8 hours following the vaccination and exercising from the gym, patient noted headache, chills, a fever of 101.2F, and constipation. Patient did report mild improvement of symptoms after taking motrin and tylenol with slow improvement of symptoms though complaints 5 days later for increased swelling of ankles/feet/wrists/ankles bilaterally of unknown cause. No new dietary changes, foods consumed, medications, or history of similar issues in the past.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Lymphadenopathy, Pain in extremity, SARS-CoV-2 test, Swelling
Clinical narrative: 3 days sore arm that spread to upper shoulder 01/22-01/24  01/24/21 at 6AM my left side of my face was swollen from eye to ear to mouth, under my neck, and swollen lymph nodes.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: 3 days sore arm that spread to upper shoulder 01/22-01/24  01/24/21 at 6AM my left side of my face was swollen from eye to ear to mouth, under my neck, and swollen lymph nodes.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Local reaction
Clinical narrative: Delayed localized reaction at injection site.  Started feeling a slight itch at the injection site exactly 7 days after receiving vaccine. By the 8th day(today) it is red and swollen, with a burning sensation. At this time the redness and swelling is 4 inches in height and 2 inches in width.  l had no  previous reaction at the site of injection besides the usual pain after the first and 2nd day.  I am applying  hydrocortisone  3-4/daily.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Arthralgia, Chills, Decreased appetite, Headache
Clinical narrative: Had onset of mild nausea and decreased appetite several hours after dose, then 12 hours after dose develops subjective fever, chills, severe body ache, severe joint aches, severe headache, and mild abdominal cramping
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza, Nausea, Pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: Had onset of mild nausea and decreased appetite several hours after dose, then 12 hours after dose develops subjective fever, chills, severe body ache, severe joint aches, severe headache, and mild abdominal cramping
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Loss of personal independence in daily activities, Lymphadenopathy
Clinical narrative: Severe axillary lymphadenopathy with onset approximately five days after injection, and persisting for at least three days after that. Very tender, interferes with daily functioning.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Fatigue, Headache, Injection site pain, Nausea
Clinical narrative: Nausea, body aches, headache, exhaustion, pain in left armpit/axillary area started 2 days post injection, pain and tenderness around injection area.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Nausea, body aches, headache, exhaustion, pain in left armpit/axillary area started 2 days post injection, pain and tenderness around injection area.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site warmth
Clinical narrative: 01/19/21 10 PM: Redness, warmth, tenderness, itchiness, swelling to injection site, affected area under 2 inches in diameter.  Took Benedryl 50 mg and Ibuprofen 800 mg. Took Ibuprofen 800 mg about 8 hours later, took Ibuprofen 600 mg about 8 hours later, took Ibuprofen 600 mg and benedryl 50 mg, took ibuprofen 400 mg about 8 hours later, took Benedryl 25 mg at bedtime. 01/21/21 12AM: Redness fading, swelling almost back to baseline, no tenderness, no itchiness. 01/26/21 10 AM: Itchiness present, dark pink injection site under 2 inches in diameter 01/26/21 8:30 PM - 8 Days post injection: Redness, warmth, itchiness, swelling to injection site, affected area just over 2 inches (2 2/8ths inches) in diameter. Took Benedryl 50 mg and Ibuprofen 800 mg. Center of injection site reading at 100.4°F via iHealth no-touch infrared forehead thermometer. An inch above read 96.9°F, an inch below read 96.9°F, my forehead read 98.4°F all temps within seconds of the previous reading. Took Benedryl 50 mg and Ibuprofen 800 mg.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Hypoaesthesia, Pyrexia, Restlessness
Clinical narrative: First Day:  At first: Tense, Restless;  Later off and on: Headache, Chills, Fever 98.2*, Hands Numb and Cold Took Tylenol with Codeine for Headache Second Day: Off and on: Headache, Chills, Fever <100*,  Hands Numb and Cold Took Tylenol with Codeine for Headache Third Day:  Off and on: Headache, Chills, Fever 100.2* Took Tylenol with Codeine for Headache